573
Views
17
CrossRef citations to date
0
Altmetric
BASIC REVIEW

Immunological Effects of Tobacco Smoking in “Healthy” Smokers

Pages 48-58 | Published online: 02 Jul 2009

REFERENCES

  • Corti C, England P. A History of Smoking. Bracken Books, London 1996
  • Lock S, Reynolds L A, Tansey E M. Ashes to Ashes: The History of Smoking and Health. Editions Rodopi B V, Amsterdam—Atlanta, GA 1998
  • Center for Disease Control. Cigarette Smoking Among Adults—United States, 2000. MMWR 2002; 51: 642–645
  • Center for Disease Control. Cigarette Smoking Among Adults—United States 2004. MMWR 2005; 54: 1122–1127
  • Center for Disease Control. Annual smoking-attributable mortality, years of potential life lost, and economic cost—United States, 1995–1999. MMWR 2002; 51: 300–303
  • Critchley J A, Capewell S. Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review. JAMA. 2003; 290: 86–97
  • U.S. Department of Health and Human Service. Reducing the Health Consequences of Smoking—25 Years of Progress: A Report of the Surgeon General. US Department of Health and Human Services, CDC, Atlanta, GA 1989, DHHS Pub. No. (CDC) 89-8411
  • Office on Smoking and Health. The Health Benefits of Smoking Cessation: A Report of the Surgeon General. US Office of the Surgeon General, Rockville, Md 1990
  • Center for Disease Control. Perspectives in Disease Prevention and Health Promotion Smoking and Cardiovascular Disease. MMWR 1984; 32: 677
  • Branden E, Koyi H, Gnarpe J, Gnarpe H, Tomlin G. Chronic Chlamydia pneumoniae infection is a risk factor for the development of COPD. Respiratory Medicine 2005; 99: 20–26
  • Nuorti J P, Butler J C, Farley M M, Harrison L H, et al. Cigarette smoking and invasive pneumococcal disease. NEJM 2000; 342: 681–89
  • Karl J D, Lebiush M, Rannon L. Cigarette smoking as a risk factor for epidemic A(H1N1) influenza in young men. N Engl J Med 1982; 307: 1042–6
  • Cohen S, Tyrrell D AJT, Russell M AH, Jarvis M J, Smith A P. Smoking, alcohol consumption, and susceptibility to the common cold. Am J Public Health 1993; 83: 1277–1283
  • Gilmour M I, Jaakkola M S, London S J, Nei A E, Rogers C A. How exposure to environmental tobacco smoke, outdoor air pollutants and increased pollen burdens influences the incidence of asthma. Environ Health Perspect 2006; 114: 627–633
  • Hoffman D, Hoffman I. The changing cigarette, 1950–1995. J Toxicol Environ Health 1997; 50: 307–364
  • Smith C J, Livingston S D, Doolittle D J. An international literature survey of IARC Group I carcinogens reported in mainstream cigarette smoke. Food Chem Toxicol 1997; 35: 1107–1130
  • Cerny E H, Levy R, Mauel J, Mpandi M, et al. Preclinical development of a vaccine against smoking. Onkologie 2002; 25: 406–411
  • Hasday J D, Bascom R, Costa J, Fitzgerald T, Dubin W. Bacterial endotoxin is an active component of cigarette smoke. Chest 1999; 115: 829–835
  • Hansson G K. Inflammation, atherosclerosis, and coronary artery disease. New Engl J Med 2005; 352: 1685–1695
  • Kraehenbuhl J P, Neutra M R. Epithelial M cells: differentiation and function. Ann Rev Cell Dev Biol 2000; 16: 301–332
  • Bouvet J, Decroix N, Pamonsinlapatham P. Stimulation of local antibody production: parenteral or mucosal vaccination. Trends Immunol 2002; 23: 209–213
  • Berneman A, et al. The specific patterns of human immunoglobin G antibodies in serum differ from those in autologous secretions. Infect Immun 1998; 66: 4163–4168
  • Kriz P, Bobak M, Kriz B. Parental smoking, socioeconomic factors, and risk of invasive meningococcal disease in children: a population based case-control study. Arch Dis Child 2000; 83: 117–121
  • Strachan D P, Cook D G. Parental smoking and allergic sensitization in children. Thorax 1998; 53: 117–123
  • Bennet K R, Reade P C. Salivary immunoglobulin A levels in normal subjects, tobacco smokers, and patients with minor aphthous ulceration. Oral Surg Med Oral Pathol 1982; 53: 461–465
  • Hersey P, Prendergast D, Edwards A. Effects of cigarette smoking on the immunes system. Med J Aust 1983; 2: 425–429
  • Jedrychowski W A, Maugeri U, Adanczyk B. Effect of smoking on serum immunoglobulins and cellular blood constituents in healthy individuals. G Ital Med Lav 1986; 8: 53–56
  • Barton J R, Riad M A, Gaze M N, Maran A GD, Feguson A. Mucosal immunodeficiency in smokers, and in patients with epithelial head and neck tumors. Gut 1990; 31: 378–382
  • Ussher M, West R, Evans P, Steptoe A, et al. Acute reduction in secretory immunoglobulin A following smoking cessation. Psychoneuroendocrinology 2004; 29: 1335–1340
  • Olson B L, McDonald M J, Jr, Gleason M J, Stookey G K, et al. Comparisons of various salivary parameters in smokers before and after the use of a nicotine-containing chewing gum. J Dent Res 1985; 64: 826–830
  • Griesel A G, Germishuys P J. Salivary immunoglobulin A levels of persons who have stopped smoking. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999; 87: 170–173
  • Evans P, Ford G D, Ford G, Hucklebridge F, et al. Social Class, sex, and age differences in mucosal immunity in a large community sample. Brain Behav Immun 2000; 14: 41–48
  • Barbee R A, Halonen M, Kaltenborn W, Lebowitz M, Burrows B. A longitudinal study of serum IgE in a community cohort: correlations with age, sex smoking, and atopic status. J Allergy Clin Immunol 1987; 79: 919–927
  • Oryszczyn M P, Annesi I, Neukirch F, Dore M F, Kauffmann F. Relationships of total IgE level, skin prick test response, and smoking habits. Ann Allergy 1991; 67: 355–358
  • Sherill D L, Halonen M, Burrows B. Relationships between total serum IgE, atopy and smoking: a twenty-year follow-up analysis. J Allergy Clin Immunol 1994; 94: 954–962
  • Jarvis D, Luczynska C, Chinn S, Burney P. The association of age, gender and smoking with total IgE and specific IgE. Clin Exp Allergy 1995; 25: 1083–1091
  • Oryszczyn M P, Annesi-Mawsano I, Charpin D, Paty E, et al. Relationships of active and passive smoking to total IgE in adults of the epidemiological study of the genetics and environment of asthma, bronchial hyper-responsiveness, and atopy (EGEA). Am J Respir Crit Care Med 2000; 161: 1241–1246
  • Raherison C, Nejjari C, Marty M L, Filleui L, et al. IgE level and Phadiatop® in an elderly population from the PAQUID cohort: relationship to respiratory symptoms and smoking. Allergy 2004; 59: 940–945
  • Miyake Y, Miyamoto S, Ohya Y, Sasaki S, et al. Relationship between active and passive smoking and total serum IgE levels in Japanese women: baseline data from Osaka maternal and child health study. Int Arch Allergy Immunol 2004; 135: 221–228
  • Court C S, Cook D G, Stachan D P. The descriptive epidemiology of house dust mite-specific and total immunoglobin E in England using an notionally representative sample. Clin Exp Allergy 2002; 32: 1033–1041
  • Liu X, Beaty T H, Deindl P, Huang S K, et al. Association between total serum IgE levels and the 6 potentially functional variants within the genes IL-4, IL-13, and IL-4RA in German children: the German multicenter atopy study. J Allergy Clin Immunol 2003; 112: 382–388
  • Gerrard J W, Heiner D C, Ko C G, Mink J, et al. Immunoglobulin levels in smokers and non-smokers. Ann Allergy 1980; 44: 261–262
  • Moszczynski P, Moszczynski P, Jr, Slowinski S. Indicators of humoral immunity and acute phase reaction in cigarette smokers. Pol Arch Med Wewn 1990; 83: 194–199
  • Moszczynski P, Zabinski A, Moszczynski P, Jr, Rutowski J, et al. Immunological findings in cigarette smokers. Toxicol Lett 2001; 118: 121–127
  • Gyllen P, Andersson B A, Qvarfordt I. Smokeless tobacco or nicotine replacement therapy has no effect on serum immunoglobulin levels. Respir Med 2004; 98: 108–114
  • Mitsunobu F, Ashida K, Hosaki Y, Tsugeno H, et al. Influence of long term cigarette smoking on immunoglobulin E mediated allergy, pulmonary function and high-resolution computed tomography lung densitometry in elderly patients with asthma. Clin Exp Allergy 2004; 34: 59–64
  • Cruijff M, Thijs C, Govaert T, Aretz K, et al. The effect of smoking on influenza, influenza vaccination efficacy and on the antibody response to influenza vaccination. Vaccine 1999; 17: 426–432
  • Hutchinson D, O'Leary C, Nixon N B, Mattey D L. Serum complexes of immunoglobulin A-alpha1 proteinase inhibitor in rheumatoid arthritis: association with current cigarette smoking and disease activity. Clin Exp Rheumatol 2002; 20: 387–391
  • Von Hertzen L, Kaprio J, Koskenvuo M, Isoaho R, Saikku P. Humoral immune response to Chlamydia pneumoniae in twins discordant for smoking. J Intern Med 1998; 244: 227–234
  • Morrison D, Strieter R M, Donnelly S C, Burdick M D, et al. Neutrophil chemokines in bronchoalveolar lavage fluid and leukocyte conditioned medium fro nonsmokers and smokers. Eur Respir J 1998; 12: 1067–1072
  • Yamaguchi E, Okazaki N, Itoh A, Abe S, et al. Interleukin 1 production by alveolar macrophages is decreased in smokers. Am Rev Respir Dis 1989; 140: 397–402
  • Wolfe W H, Miner J C, Michalek J E. Immunological parameters in current and former US Air Force personnel. Vaccine 1993; 11: 545–547
  • Vilcek J. The cytokines: An overview. The Cytokine Handbook, Fourth edition, A G Thomson, M T Lotze. Elsevier Science, London 2003
  • Strieter R M, Belperio J A, Keane M P. Host innate defenses in the lung: the role of cytokines. Curr Opin Infect Dis 2003; 16: 193–198
  • Joos L, McIntyre L, Ruan J, Connett J E, et al. Association of IL-1β, and IL-1 receptor antagonist haplotypes with rate of decline in lung function in smokers. Thorax 2001; 56: 863–866
  • Karjalainen J, Julkkonen J, Hurme M, Joos L, Pare P K, Sandford A. IL-1 haplotypes and lung function decline. Thorax 2002; 57: 561–562
  • McCrea K A, Ensor J E, Nall K, Bleecker E R, Hasday J D. Altered Cytokine regulation in the lungs of cigarette smokers. Am J Respir Crit Care Med 1994; 150: 696–703
  • Kuschner W G, D'Alessandro A, Wong H, Blanc P K. Dose dependent cigarette smoking related inflammatory responses in healthy adults. Eur Respir J 1996; 9: 1989–1994
  • Mikuniya T, Nagai S, Tsutsumi T, Morita K, et al. Proinflammatory or regulatory cytokines released from BALF macrophages of healthy smokers. Respiration 1999; 66: 419–426
  • Ohta T, Yamashita N, Maruyama M, Sugiyama E, Kobayashi M. Cigarette smoking decreases ineerleukin-8 secretion by human alveolar macrophages. Respir Med 1998; 92: 922–927
  • Kotani N, Hashimoto H, Sessler D I, Yoshida H, et al. Smoking deceases alveolar macrophage function during anesthesia and surgery. Anesthesiology 2000; 92: 1268–1277
  • Morrison D, Strieter R M, Donnelly S C, Burdick M D, et al. Neutrophil chemokines in bronchoalveolar lavage fluid and leukocyte conditioned medium fro nonsmokers and smokers. Eur Respir J 1998; 12: 1067–1072
  • Soliman D M, Twigg H L, III. Cigarette smoking decreases bioactive interlieukin-6 secretion by alveolar macrophages. Am J Physiol Lung Cell Mol Physiol 1992; 63: L471–L478
  • Brown G P, Iwamoto G K, Monick M M, Gunninghake G W. Cigarette smoking deceases interleukin-1 release by human alveolar macrophages. Am J Physiol Cell Physiol 1989; 256: C260–C264
  • Laan M, Qvarfordt I, Riise G C, Andersson A A. Increased levels of interleukin-16 in the airways of tobacco smokers: relationship with peripheral blood T lymphocytes. Thorax 1999; 54: 911–916
  • Vernooy J H, Kucukayacan M, Jacobs J A, Chavannes N H, et al. Local and systemic inflammation in patients with chronic obstruction pulmonary disease. Am J Respir Crit Care Med 2002; 166: 1218–1224
  • Schulz C, Wolf K, Harth M, Kratzel K, et al. Expression and release of interleukin-8 by human bronchial epithelial cells from patients with chronic obstructive pulmonary disease, smokers and never smokers. Respiration 2003; 70: 254–261
  • Takanashi S, Hasegawa Y, Kanehira Y, Yamamoto K, et al. Interleukin-10 level in sputum is reduced in bronchial asthma, COPD and in smokers. Eur Respir J 1999; 14: 309–314
  • McKay A, Komai-Koma M, MacLeod K J, Campbell C C, et al. Interleukin-18 levels in induced sputum are reduced in asthmatic and normal smokers. Clin Exp Allergy 2004; 34: 904–910
  • Majori M, Corradi M, Caminati A, Cacciani G, et al. Predominate Th-1 cytokine pattern in peripheral blood from subjects with chronic obstructive pulmonary disease. J Allergy Clin Immunol 1999; 103: 458–462
  • Byron K A, Varigos G A, Wootton A M. IL-4 production is increased in cigarette smokers. Clin Exp Immunol 1994; 95: 333–336
  • Wirtz P H, von Kanel R, Kunz-Ebrecht S, Ehlert U, Fischer J E. Enhanced glucocorticoid sensitivity of cytokine release from circulating leukocytes stimulated with lipopolysaccharide in healthy male smokers. Brain Behav Immun 2004; 18: 536–543
  • Graswinckel J EM, ban der Velden U, van Winkelhoff A J, Hoek F J, et al. Plasma antibody levels in periodontitis patients and controls. J Clin Periodontol 2004; 31: 562–568
  • Qvarfordt I, Riise G C, Andersson B A, Larsson S. IgG subclasses in smokers with chronic bronchitis and recurrent exacerbations. Thorax 2001; 56: 445–449
  • Conti P, Kempuraj D, Frydas S, Kandere K, et al. IL-10 subfamily members: IL-19, IL-20, IL-22, IL-24 and IL-26. Immunol Lett 2003; 88: 171–174
  • Jordan W J, Eskdale J, Boniotto M, Lennon G P, et al. Human IL-19 regulates immunity through auto-induction of IL-19 and production of IL-10. Eu J Immunol 2005; 35: 1576–1582
  • Hagiwara E, Takahashi K, Okubo T, Ohno S, et al. Cigarette smoking depletes cells spontaneously secreting Th 1 cytokines in human airway. Cytokine 2001; 14: 121–126
  • Miller L G, Goldstein G, Murphy M, Ginns L C. Reversible alterations in immunogrgulatory T cells in smoking. Analysis by monoclonal antibodies and flow cytometry. Chest 1982; 82: 526–529
  • Costabel U, Bross K J, Reuter C, Ruhle K H, Matthys H. Alterations in immunoregulatory T cells subsets in cigarette smoker. A phenotypic analysis of bronchoaleveolar and blood lymphocytes. Chest 1986; 90: 39–44
  • Lams B EA, Lousa A R, Rees P J, Lee T H. Subepithelial immunopathology of the large airways in smokers with and without chronic obstructive pulmonary disease. Eur Respir J 2000; 15: 512–516
  • Snapper C M, Pecanha L MT, Levine A D, Mond J J. IgE class switching is critically dependent upon the nature of the B-cell activator, in addition to the presence of IL-4. J Immunol 1991; 147: 1163–1170

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.